Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver

Journal of Hepatology

Volumn 32, Issue 5, 2000, Pages 805-811

  Blanc, Jean Frédéric ^a,b   Ledinghen, Victor De ^b   Bernard, Pierre Henri ^a   Verneuil, Hubert De ^b   Winnock, Maria ^b   Le Bail, Brigitte ^b   Carles, Jacques ^b   Saric, Jean ^b   Balabaud, Charles ^a,b   Bioulac Sage, Paulette ^b  

^a Service Hépato gastroentérologie   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

C282Y gene mutations; Hepatocellular carcinoma; HFE gene mutations; Non cirrhotic liver

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; HETEROZYGOSITY; HUMAN; INCIDENCE; IRON OVERLOAD; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL;

EID: 0034102671     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80250-0     Document Type: Article

References (45)

1. Turlin B, Juguet F, Moirand R, Le Quilleuc D, Loréal O, Campion J-P, et al. Increased liver iron stores in patients with hepatocellular carcinoma developed on a non-cirrhotic liver. Hepatology. 22:1995;446-450.
2. Deugnier YM, Guyader D, Crantok L, Lopez JM, Turlin B, Yaouanq J, et al. Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases. Gastroenterology. 104:1993;228-234.
3. Fellows IW, Stewart M, Jeffcoate WJ, Smith PG, Toghill PJ. Hepatocellular carcinoma in primary haemochromatosis in the absence of cirrhosis. Gut. 29:1988;1603-1606.
4. Blumberg RS, Chopra S, Ibrahim R, Crawford J, Farraye FA, Zeldis JB, et al. Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal fibrosis. Gastroenterology. 95:1988;1399-1402.
5. Thompson NP, Stansby G, Jarmulowicz M, Hobbs KE, McIntyre N. Hepatocellular carcinoma arising in non-cirrhotic haemochromatosis. HPB Surgery. 8:1995;163-166.
6. Goh J, Larney V, Ennis K, Clarke G, Callagy G, O'Keane JC, et al. Hepatocellular carcinoma may develop without cirrhosis in haemochromatosis. [abstract] Hepatology. 26:1997;514A.
7. Tomao S, Romiti A, Mozzicafreddo A, Raffaele M, Zullo A, Antonaci A. Onset of hepatocellular carcinoma in a non-cirrhotic patient affected with haemochromatosis. Oncol Rep. 5:1998;723-725.
8. De Tomas J, Louredo A, Turegano F, Alonso A, Martin-Merino MR. Hepatocellular carcinoma in a non-cirrhotic coal miner with secondary haemochromatosis. Eur J Gastroenterol Hepatol. 9:1997;633-634.
9. Chenoufi N, Loreal O, Drenou B, Cariou S, Hubert N, Leroyer P, et al. Iron may induce both DNA synthesis and repair in rat hepatocytes stimulated by EGF/pyruvate. J Hepatol. 26:1997;650-658.
10. Adams PC, Chakrabarti S. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. Gastroenterology. 114:1998;319-323.
11. Bacon B. Diagnosis and management of hemochromatosis. Gastroenterology. 113:1997;995-999.
12. Burt MJ, George PM, Upton JD, Collett JA, Frampton CM, Chapman TM, et al. The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut. 43:1998;830-836.
13. Crawford DH, Jazwinska EC, Cullen LM, Powell LW. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology. 114:1998;1003-1008.
14. Piperno A, Sampietro M, Pietrangelo A, Arosio C, Lupica L, Montosi G, et al. Heterogeneity of hemochromatosis in Italy. Gastroenterology. 114:1998;996-1002.
15. Searle J, Kerr JFR, Halliday JW, Powell LW. Iron storage disease. MacSween RNM, Anthony PP, Scheuer PJ, Burt AD, Portmann BC. Pathology of the Liver. 3rd ed. 1994;219-241 Churchill Livingstone, Edinburgh.
16. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology. 24:1996;289-293.
17. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 13:1996;399-408.
18. Akriviadia EA, Llovet JM, Efremidis SC, Shouval D, Canelo R, Ringe B, et al. Hepatocellular carcinoma. Br J Surg. 85:1998;1319-1331.
19. Kalayci C, Johnson SE, Davies SE, Williams R. Hepatitis B virus related hepatocellular carcinoma in the non-cirrhotic liver. J Hepatol. 12:1991;54-59.
20. Marcellin P, Thiers V, Degott C, Franco D, Belghitti J, Castaing D, et al. Hepatocellular carcinoma with normal adjacent liver. Hepatitis B virus DNA status. J Hepatol. 8:1989;249-253.
21. De Mitri MS, Poussin K, Baccarini P, Pontisso P, D'Errico A, Simon N, et al. HCV-associated liver cancer without cirrhosis. Lancet. 345:1995;413-415.
22. Herr W, Gerken G, Poralla T, Immenschuh S, Schirmacher P, Steegmüller KW, et al. Hepatitis C virus associated primary hepatocellular carcinoma in a non-cirrhotic liver. J Clin Invest. 71:1993;49-53.
23. El-Refaie A, Savage K, Bhattacharya S, Khakoo S, Harrison TJ, El-Batanony M, et al. HCV-associated hepatocellular carcinoma without cirrhosis. J Hepatol. 24:1996;277-285.
24. Bréchot C, Jaffredo F, Lagorce D, Gerken G, Meyer Zum Büschenfelde KH, Papakonstontinou A, et al. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action. J Hepatol. 29:1998;173-183.
25. Willis G, Wimperis JZ, Lonsdale R, Jennings BA. Haemochromatosis gene mutation in hepatocellular cancer. Lancet. 350:1997;565-566.
26. Bralet M-P, Degott C, Belghiti J, Terris B. Prevalence of the haemochromatosis gene mutation in non-cirrhotic liver with hepatocellular carcinoma. J Hepatol. 28:1998;740-741.
27. Aldersley MA, Komolmit P, Hamlin PJ, Markham Af, Wyatt JI, Robinson PA. Increased prevalence of the hemochromatosis gene mutations in patients with hepatocellular carcinoma. [abstract] Gastroenterology. 116:1999;A1182.
28. Cauza E, Ulrich-Pur H, Peck-Radosavljevic M, Novacek G, Gschwantler M, Rudolfstiftung KH, et al. HFE mutations in patients with hepatocellular carcinoma. [abstract] Gastroenterology. 116:1999;A1195.
29. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet. 349:1997;321-323.
30. Sampietro M, Piperno A, Lupica L, Arosio C, Vergani A, Corbetta N, et al. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology. 27:1998;181-184.
31. Elder GH. Mutations in the hemochromatosis gene, porphyria cutanea tarda, and iron overload. Hepatology. 27:1998;289-291.
32. Conte D, Manachino D, Colli A, Guala A, Aimo G, Andreoletti M, et al. Prevalence of genetic hemochromatosis in a cohort of Italian patients with diabetes mellitus. Ann Intern Med. 128:1998;370-373.
33. Kwan T, Leber B, Ahuja S, Carter R, Gerstein HC. Patients with type 2 diabetes have a high frequency of the C282Y mutation of the hemochromatosis gene. Clin Invest Med. 21:1998;251-257.
34. George DK, Goldwurm S, MacDonald GA, Cowley LL, Walker NI, Ward PJ, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased hepatic fibrosis. Gastroenterology. 114:1998;311-318.
35. Moirand R, Mortaji A, Loréal O, Paillard F, Brissot P, Deugnier Y. Liver iron overload with normal transferrin saturation: a new syndrome. Lancet. 349:1997;95-97.
36. Deugnier Y, Moirand R, Jouanolle AM, Le Gall JY, Brissot P, David V. HLA-H mutations in patients with iron overload and normal transferrin saturation. [abstract] Hepatology. 26:1997;199A.
37. Braga C, La Vecchia C, Negri E, Franceshi S. Attributable risks for hepatocellular carcinoma in Northern Italy. Eur J Cancer. 33:1997;629-634.
38. Blanc J-F, De Lédinghen V, Trimoulet P, Le Bail B, Bernard P-H, et al. Premalignant lesions and hepatocellular carcinoma in a non-cirrhotic alcoholic patient with iron overload and normal transferrin saturation. J Hepatol. 30:1999;325-329.
39. Deugnier Y, Turlin B, Loréal O. Iron and neoplasia. J Hepatol. 28:1998;21-25.
40. Moyo VM, Makunike R, Gangaidzo IT, Gordeuk VR, McLaren CE, Khumalo H, et al. African iron overload and hepatocellular carcinoma. Eur J Haematol. 60:1998;28-34.
41. Vautier G, Bomford AB, Portmann BC, Metivier E, Williams R, Ryder SD. p53 mutations in British patients with hepatocellular carcinoma: clustering in genetic hemochromatosis. Gastroenterology. 117:1999;154-160.
42. Ramm GA, Crawford DH, Powell LW, Walker NI, Fletcher LM, Halliday JW. Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy. J Hepatol. 26:1997;584-592.
43. Jouanolle AM, Fergelot P, Raoul ML, Gandon G, Roussey M, Deugnier Y, et al. Prevalence of the C282Y mutation in Brittany: penetrance of genetic hemochromatosis? Ann Genet. 41:1998;195-198.
44. Cogswell ME, McDonnell SM, Khoury MJ, Franks AL, Burke W, Brittenham G. Iron overload, public health, and genetics: evaluating the evidence for hemochromatosis screening. Ann Intern Med. 129:1998;971-979.
45. Adams PC. Iron overload in viral and alcoholic liver disease. J Hepatol. 28:1998;19-20.